Genethera Stock Market Value
| GTHR Stock | USD 0.0001 0.00 0.00% |
| Symbol | GeneThera |
GeneThera 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to GeneThera's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of GeneThera.
| 12/09/2024 |
| 01/08/2025 |
If you would invest 0.00 in GeneThera on December 9, 2024 and sell it all today you would earn a total of 0.00 from holding GeneThera or generate 0.0% return on investment in GeneThera over 30 days. GeneThera is related to or competes with Novo Nordisk, Novo Nordisk, Vertex Pharmaceuticals, CSL, CSL, and Regeneron Pharmaceuticals. GeneThera, Inc., a biotechnology company, develops molecular assays and therapeutics for the detection and treatment of ... More
GeneThera Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure GeneThera's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess GeneThera upside and downside potential and time the market with a certain degree of confidence.
GeneThera Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for GeneThera's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as GeneThera's standard deviation. In reality, there are many statistical measures that can use GeneThera historical prices to predict the future GeneThera's volatility.GeneThera Backtested Returns
We have found three technical indicators for GeneThera, which you can use to evaluate the volatility of the firm. The company retains a Market Volatility (i.e., Beta) of 0.0, which attests to not very significant fluctuations relative to the market. the returns on MARKET and GeneThera are completely uncorrelated.
Auto-correlation | 0.00 |
No correlation between past and present
GeneThera has no correlation between past and present. Overlapping area represents the amount of predictability between GeneThera time series from 9th of December 2024 to 24th of December 2024 and 24th of December 2024 to 8th of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of GeneThera price movement. The serial correlation of 0.0 indicates that just 0.0% of current GeneThera price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
GeneThera lagged returns against current returns
Autocorrelation, which is GeneThera pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting GeneThera's pink sheet expected returns. We can calculate the autocorrelation of GeneThera returns to help us make a trade decision. For example, suppose you find that GeneThera has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
GeneThera regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If GeneThera pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if GeneThera pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in GeneThera pink sheet over time.
Current vs Lagged Prices |
| Timeline |
GeneThera Lagged Returns
When evaluating GeneThera's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of GeneThera pink sheet have on its future price. GeneThera autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, GeneThera autocorrelation shows the relationship between GeneThera pink sheet current value and its past values and can show if there is a momentum factor associated with investing in GeneThera.
Regressed Prices |
| Timeline |
Pair Trading with GeneThera
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GeneThera position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneThera will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to GeneThera could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GeneThera when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GeneThera - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GeneThera to buy it.
The correlation of GeneThera is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GeneThera moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GeneThera moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GeneThera can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for GeneThera Pink Sheet Analysis
When running GeneThera's price analysis, check to measure GeneThera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneThera is operating at the current time. Most of GeneThera's value examination focuses on studying past and present price action to predict the probability of GeneThera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneThera's price. Additionally, you may evaluate how the addition of GeneThera to your portfolios can decrease your overall portfolio volatility.